BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 30114221)

  • 1. Family history-based colorectal cancer screening in Australia: A modelling study of the costs, benefits, and harms of different participation scenarios.
    Dillon M; Flander L; Buchanan DD; Macrae FA; Emery JD; Winship IM; Boussioutas A; Giles GG; Hopper JL; Jenkins MA; Ait Ouakrim D
    PLoS Med; 2018 Aug; 15(8):e1002630. PubMed ID: 30114221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-Effectiveness and National Effects of Initiating Colorectal Cancer Screening for Average-Risk Persons at Age 45 Years Instead of 50 Years.
    Ladabaum U; Mannalithara A; Meester RGS; Gupta S; Schoen RE
    Gastroenterology; 2019 Jul; 157(1):137-148. PubMed ID: 30930021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SMARTERscreen protocol: a three-arm cluster randomised controlled trial of patient SMS messaging in general practice to increase participation in the Australian National Bowel Cancer Screening Program.
    McIntosh JG; Emery JD; Wood A; Chondros P; Goodwin BC; Trevena J; Wilson C; Chang S; Hocking J; Campbell T; Macrae F; Milley K; Lew JB; Nightingale C; Dixon I; Castelli M; Lee N; Innes L; Jolley T; Fletcher S; Buchanan L; Doncovio S; Broun K; Austin G; Jiang J; Jenkins MA
    Trials; 2023 Nov; 24(1):723. PubMed ID: 37957680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating the effects of a risk-adapted screening program for familial colorectal cancer in individuals between 25 and 50 years of age: study protocol for the prospective population-based intervention study FARKOR.
    Hoffmann S; Crispin A; Lindoerfer D; Sroczynski G; Siebert U; Mansmann U; Consortium F
    BMC Gastroenterol; 2020 May; 20(1):131. PubMed ID: 32370777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening practices of Australian men and women categorized as "at or slightly above average risk" of colorectal cancer.
    Ait Ouakrim D; Lockett T; Boussioutas A; Keogh L; Flander LB; Winship I; Giles GG; Hopper JL; Jenkins MA
    Cancer Causes Control; 2012 Nov; 23(11):1853-64. PubMed ID: 23011536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term benefits and harms of early colorectal cancer screening in German individuals with familial cancer risk.
    Sroczynski G; Hallsson LR; Mühlberger N; Jahn B; Rehms R; Hoffmann S; Crispin A; Lindoerfer D; Mansmann U; Siebert U
    Int J Cancer; 2024 Feb; 154(3):516-529. PubMed ID: 37795630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness analysis of different screening strategies for colorectal cancer in Guangzhou, southern China: a Markov simulation analysis based on natural community screening results.
    Zhou Q; Li HL; Li Y; Gu YT; Liang YR; Liu HZ; Li K; Dong H; Chen YY; Lin GZ
    BMJ Open; 2021 Sep; 11(9):e049581. PubMed ID: 34489283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Costs and Projected Effect of a Federally Qualified Health Center-Based Mailed Colorectal Cancer Screening Program in Texas.
    Olmstead T; Spencer JC; Kluz N; Zhan FB; Shokar NK; Pignone M
    Prev Chronic Dis; 2024 May; 21():E30. PubMed ID: 38696253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increasing bowel cancer screening using SMS in general practice: the SMARTscreen cluster randomised trial.
    McIntosh JG; Jenkins M; Wood A; Chondros P; Campbell T; Wenkart E; O'Reilly C; Dixon I; Toner J; Martinez-Gutierrez J; Govan L; Emery JD
    Br J Gen Pract; 2024 Apr; 74(741):e275-e282. PubMed ID: 38164588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of colorectal cancer screening protocols in urban Chinese populations.
    Huang W; Liu G; Zhang X; Fu W; Zheng S; Wu Q; Liu C; Liu Y; Cai S; Huang Y
    PLoS One; 2014; 9(10):e109150. PubMed ID: 25285526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-utility analysis of expanding the colorectal cancer screening policy in Flanders.
    Lelie M; Parmentier R; Simoens S; Annemans L; Putman K
    Public Health; 2024 Jun; 231():142-147. PubMed ID: 38688167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Institutional (mis)trust in colorectal cancer screening: a qualitative study with Greek, Iranian, Anglo-Australian and Indigenous groups.
    Ward PR; Coffey C; Javanparast S; Wilson C; Meyer SB
    Health Expect; 2015 Dec; 18(6):2915-27. PubMed ID: 25271975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colorectal cancer screening: why immunochemical fecal occult blood tests may be the best option.
    Flitcroft KL; Irwig LM; Carter SM; Salkeld GP; Gillespie JA
    BMC Gastroenterol; 2012 Dec; 12():183. PubMed ID: 23272939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The projected health and economic impact of increased colorectal cancer screening participation among Canadians by income quintile.
    Adegbulugbe AA; Farah E; Ruan Y; Yong JHE; Cheung WY; Brenner DR
    Can J Public Health; 2024 Jun; 115(3):384-394. PubMed ID: 38502494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population-level impact of the BMJ Rapid Recommendation for colorectal cancer screening: a microsimulation analysis.
    van Duuren LA; Bulliard JL; Mohr E; van den Puttelaar R; Plys E; Brändle K; Corley DA; Froehlich F; Selby K; Lansdorp-Vogelaar I
    BMJ Open Gastroenterol; 2024 May; 11(1):. PubMed ID: 38724254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scoring colorectal cancer risk with an artificial neural network based on self-reportable personal health data.
    Nartowt BJ; Hart GR; Roffman DA; Llor X; Ali I; Muhammad W; Liang Y; Deng J
    PLoS One; 2019; 14(8):e0221421. PubMed ID: 31437221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving colon cancer screening in community clinics.
    Davis T; Arnold C; Rademaker A; Bennett C; Bailey S; Platt D; Reynolds C; Liu D; Carias E; Bass P; Wolf M
    Cancer; 2013 Nov; 119(21):3879-86. PubMed ID: 24037721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ability of known susceptibility SNPs to predict colorectal cancer risk for persons with and without a family history.
    Jenkins MA; Win AK; Dowty JG; MacInnis RJ; Makalic E; Schmidt DF; Dite GS; Kapuscinski M; Clendenning M; Rosty C; Winship IM; Emery JD; Saya S; Macrae FA; Ahnen DJ; Duggan D; Figueiredo JC; Lindor NM; Haile RW; Potter JD; Cotterchio M; Gallinger S; Newcomb PA; Buchanan DD; Casey G; Hopper JL
    Fam Cancer; 2019 Oct; 18(4):389-397. PubMed ID: 31209717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Reducing the Recommended Colorectal Cancer Screening Age With Cancer Incidence, Mortality, and Costs in Canada Using OncoSim.
    Kalyta A; Ruan Y; Telford JJ; De Vera MA; Peacock S; Brown C; Donnellan F; Gill S; Brenner DR; Loree JM
    JAMA Oncol; 2023 Oct; 9(10):1432-1436. PubMed ID: 37471076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Impact of a Comprehensive Risk Prediction Model for Colorectal Cancer on a Population Screening Program.
    Saya S; Emery JD; Dowty JG; McIntosh JG; Winship IM; Jenkins MA
    JNCI Cancer Spectr; 2020 Oct; 4(5):pkaa062. PubMed ID: 33134836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.